Drug intelligence / Profile preview

iMDF

Development stage
Preclinical
Lead developer
Megakaryon
Modality
Recombinant Proteins and Enzymes, iPSCs → Pluripotent Stem Cells → Stem Cell Therapies → Cell Therapies
Administration
Topical
01

Overview

iMDF (iPS-Megakaryocyte Derived Factors) is a growth factor cocktail biologic developed by Megakaryon Corporation. It is composed of a mixture of growth factors secreted and purified from mature megakaryocytes that are derived from human induced pluripotent stem (iPS) cells. The product is designed to provide trophic and regenerative activity or functional components for a variety of applications, including pharmaceutical products, cosmetics, and as a cell culture medium additive. Megakaryon utilizes its proprietary technology to mass-produce mature megakaryocytes from immortalized megakaryocyte cell lines to extract and purify these factors for commercial and clinical use. The product is currently in preclinical development for broad regenerative and functional applications.

Brand names
iMDF
Other names
iPS-Megakaryocyte Derived FactorsiMDF growth factor cocktail

Beyond the preview

Go deeper on iMDF.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on iMDF.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call